Congenital anomalies after prenatal ecstasy exposure.
Prospective follow-up of 136 babies exposed to ecstasy in utero indicated that the drug may be associated with a significantly increased risk of congenital defects (15.4% [95% CI 8.2-25.4]). Cardiovascular anomalies (26 per 1000 livebirths [3.0-90.0]) and musculoskeletal anomalies (38 per 1000 [8.0-109.0]) were predominant.
McElhatton
P R
PR
Bateman
D N
DN
Evans
C
C
Pughe
K R
KR
Thomas
S H
SH
D000014:Abnormalities, Drug-Induced / Q000453:epidemiology* / Q000209:etiology; D000293:Adolescent; D000328:Adult; D005260:Female; D006213:Hallucinogens / Q000009:adverse effects*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects*; D011247:Pregnancy; D011446:Prospective Studies
D006213:Hallucinogens; D018817:N-Methyl-3,4-methylenedioxyamphetamine